Source link : https://www.newshealth.biz/health-news/insulin-therapy-de-escalation-to-fixed-ratio-combo-safe/
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor agonist lixisenatide (iGlarLixi) provides similar glucose control, with added benefits including weight reduction, without increasing the risk for hypoglycemia, new research showed. “This is the […]
Author : News Health
Publish date : 2024-09-23 09:21:01
Copyright for syndicated content belongs to the linked Source.
Categories